Introduction
============

Sepsis and septic shock are crucial health problems worldwide[@b1-idr-11-125],[@b2-idr-11-125] and are the leading causes of death in many intensive care units. Since sepsis and septic shock have poor outcomes with high mortality rates, the 4 versions of the Surviving Sepsis Campaign (SSC) aim to decrease the mortality rates.[@b3-idr-11-125] A worldwide observational study revealed that the mortality rate decreased 0.7% per site for every 3 months of participation in the SSC.[@b4-idr-11-125] Thus, compliance to the bundles of the SSC is vital.

According to the SSC 2012,[@b5-idr-11-125] management of sepsis was divided into 2 bundles: 3-h bundle and 6-h bundle. In the 3-h SSC bundle, the administration of intravenous antibiotics should be initiated within the first hour of recognition of sepsis. A study by Kumar et al[@b6-idr-11-125] revealed that every 1 h of delayed antibiotic administration will reduce the survival by 7.6%. Multiple observational studies confirmed that delays in antibiotic administration were associated with mortality.[@b7-idr-11-125]--[@b10-idr-11-125] In addition to antibiotic administration, lactate should be measured at the time of diagnosis of sepsis. Lactate level is used for sepsis recognition and as a guide for resuscitation. Unfortunately, these 2 components of the bundles are often omitted due to many factors that include managing the protocol and limited resources. In addition, the IMPreSS study, conducted in 2015, showed that compliance in the measurement of lactate in Asia was only 48.3%.[@b11-idr-11-125]

The majority of septic patients admitted to the medical intensive care unit (MICU) are from 2 sources: hospital wards and the emergency department (ED).[@b12-idr-11-125] Since the settings of these sources are different, the timing of the compliance of appropriate antibiotic administration and lactate measurement is different. One study revealed different times of antibiotic administration between hospital wards and the ED but lacked data on the timing intervals; also, no timing of lactate measurement was reported.[@b13-idr-11-125]

The objectives of this study were to determine the times of each step in antibiotic administration and the time of lactate measurement and to compare the results between the hospital wards and the ED in a tertiary hospital in southern Thailand.

Patients and methods
====================

Study design and setting
------------------------

This study was a single-center retrospective study conducted in septic shock patients who were transferred to the MICU from 2 sources: a hospital ward and the ED at Songklanagarind Hospital. This hospital is an 816-bed university-affiliated hospital that has 40 adult wards and a 10-bed MICU. Patient data collected from the ICU Sepsis database electronic medical records tracked the hospital number codes from January 2015 to December 2016. At the time of the study, sepsis management in our hospital followed the SSC 2012 bundles. The study protocol was approved by The Research Ethics Committee of Faculty of Medicine, Prince of Songkla University (REC 60-041-14-1). Patient consent to review their medical records was not required by the research ethics committee as the data collected from electronic medical records were anonymous, confidential, and not linked to the individuals.

Study population
----------------

Patients were included if they were 18 years old or older, diagnosed as suffering from septic shock, and transferred to the MICU. For patients transferred from the wards, we selected only patients who developed sepsis at the wards. If a patient had repeated episodes of septic shock, we chose only the first episode. Septic shock was defined as sepsis-induced hypotension that persisted despite adequate fluid resuscitation along with the presence of hypoperfusion abnormalities or organ dysfunction based on the 1992 consensus definition.[@b14-idr-11-125] The exclusion criteria were incomplete data, referred cases, and septic patients who did not receive antibiotics.

Data collection
---------------

The collected data included patient demographic data, Sequential Organ Failure Assessment score, source of MICU admission, presumed cause(s) of infection, date of admission, time of admission, weekend admission (admission to the MICU on Saturday or Sunday), MICU length of stay, hospital stay, and discharge type.

The time of diagnosis of sepsis was marked as "Time Zero", defined as the systemic response to infection manifested by 2 or more of the following conditions resulting from infection: 1) temperature \>38°C or \<36°C; 2) heart rate \>90 beats/min; 3) respiratory rate \>20 breaths/min or PaCO~2~ \<32 mmHg; and 4) white blood cell count \>12,000/μL, \<4,000/μL, or \>10% immature (band) forms adopted from the 1992 consensus definition.[@b14-idr-11-125] Hemoculture time is the time the doctors ordered the hemoculture. Antibiotic prescription time was the time the doctors ordered the antibiotic(s). The time to receive antibiotics was the time patients were administered the antibiotic(s), which was recorded on the electronic medical records. In addition, hemoculture results with the sensitivity testing of the antibiotics were recorded for further analysis for the appropriateness of the type of antibiotics that were prescribed. An appropriate antibiotic was defined as susceptibility to at least one empiric antibiotic therapy by subsequent in vitro susceptibility of the pathogen.[@b15-idr-11-125]

Outcome measures
----------------

Primary outcomes were the interval from time zero to antibiotic administration and lactate measurement. Secondary outcomes were the percentage of patients who had received appropriate antibiotic(s) and factors that affected 28-day mortality.

Statistical analysis
--------------------

Categorical data were demonstrated as percentages. Continuous data are shown as mean ± standard deviation or median with minimum and maximum interquartile range (IQR) depending on the distribution of the data. The data were tested for normality using the Kolmogorov--Smirnov goodness-of-fit test. For primary outcomes, the chi-square test was performed for categorical data. Student's *t*-test or Mann--Whitney *U* test was selected for continuous variable analysis. For secondary outcomes, selected variables with *P*\<0.10 were introduced into a multiple logistic regression model after testing for association. Odds ratios (ORs) and their 95% confidence intervals (CIs) were used to identify the significant independent factors influencing 28-day mortality. Two-tailed values of *P*\<0.05 were deemed statistically significant. All statistical analyses were computed with R software version 3.3.1 (R Foundation for Statistical Computing, Vienna, Austria).

Results
=======

One hundred and fifty septic shock patients admitted into our MICU were included in the study: 41.3% (62/150) from the ED and 58.7% (88/150) from the wards ([Figure 1](#f1-idr-11-125){ref-type="fig"}). Internal medicine wards were the predominant source with 76.1% (67/88). Patients admitted from the wards had a significantly higher number of malignancies as comorbidities and longer MICU length of stay. The most common type of infection was health care-associated infection, and the most common infection was pneumonia. There was no significant 28-day hospital mortality difference between critically ill septic patients admitted to the wards vs those admitted to the MICU from the ED (47.7% vs 35.5%, *P*=0.13). Details of the clinical characteristics stratified by admission sources are presented in [Table 1](#t1-idr-11-125){ref-type="table"}. More than half of the patients had positive culture results, and most samples for analysis were blood. Two-thirds of organisms were Gram-negative bacteria ([Table 2](#t2-idr-11-125){ref-type="table"}). The initial number of empirical antibiotics used ranged from 1 to 3, and carbapenems were frequently prescribed ([Table 3](#t3-idr-11-125){ref-type="table"}).

Primary outcomes
----------------

Patients admitted from wards had a significantly longer median interval (h \[IQR\]) from the onset of severe sepsis or septic shock or both to receive the antibiotic(s) compared with patients admitted from the ED (4.84 \[3.5--8.11\] vs 2.04 \[1.37--3.54\], *P*\<0.01). Likewise, we found significantly longer time intervals (h \[IQR\]) in patients from the wards vs patients from the ED from time zero to hemoculture (1.3 \[0.2--5.4\] vs 0.4 \[0.1--1.1\], *P*=0.01), time from hemoculture to antibiotic prescription (1.1 \[0.3--3.0\] vs 0.6 \[0.2--1.3\], *P*=0.03), and time from antibiotic prescription to time patients received the antibiotics (0.8 \[0.5--1.5\] vs 0.6 \[0.3--1.0\], *P*=0.02) ([Figure 2](#f2-idr-11-125){ref-type="fig"}). Overall lactate measurement was done in only 40% of patients at time zero ([Table 1](#t1-idr-11-125){ref-type="table"}). However, the lactate level measurement time intervals (h \[IQR\]) from time zero were not different between those admitted from the wards and those from the ED (1.6 \[0.2--2.7\] vs 1.6 \[0.9--3.0\], *P*=0.85).

Secondary outcomes
------------------

In a subgroup of 85 patients with positive culture results, the overall appropriate use of antibiotics was 66/85 (77.6%). The numbers of patients from the ED and the hospital wards who received the appropriate antibiotic(s) were 36/42 (90%) and 30/43 (69.8%), respectively (*P*=0.01). Patients who received the appropriate antibiotic regimen had a lower 28-day mortality compared with patients who did not (21/66 \[31.8%\] vs 12/19 \[63.2%\], *P*=0.03). We also analyzed factors that affected 28-day mortality adjusted for severity. Multivariate analysis showed that a higher risk-adjusted 28-day mortality was associated with antibiotic monotherapy (OR: 19.3, 95% CI: 2.4--153.1, *P*\<0.01) and admission on a weekend (OR: 24.4, 95% CI: 2.9--199.8, *P*\<0.01) ([Table 4](#t4-idr-11-125){ref-type="table"}).

Discussion
==========

To the authors' knowledge, this is the first study to explore the time intervals of the stages in the process of antibiotic administration in Thailand. Our study found that a significantly longer time interval occurred from sepsis to antibiotic administration in septic shock patients from the wards compared with those from the ED. The time interval from sepsis to lactate measurement was insignificantly different between the wards and the ED.

The SSC recommends that patients should receive the appropriate antibiotic within 1 h. However, many worldwide surveys showed failure to accomplish this goal. However, this recommendation is not impossible to accomplish. For example, a study from the New York State Department of Health reported that the median time interval to the administration of antibiotics in the ED was 0.95 h.[@b16-idr-11-125] However, a study in northern California revealed that the median time interval for administration of antibiotics was 2.1 h (IQR: 1.4--3.1) in an ED.[@b17-idr-11-125] The median time interval from first medical contact to receive an antibiotic in another study in the United States was 4.2 h (IQR: 2.7--8.0).[@b18-idr-11-125]

The interval of antibiotic administration depends on the level of the hospital. A study by Mok et al[@b13-idr-11-125] in a university-affiliated hospital in Canada showed a similar trend to our study. That study revealed that the intervals between ordering and administration differed significantly for patients in the wards (5.7 h) compared with those who had disease onset in the intensive care unit (4.0 h) and those who had disease onset in the ED (3.3 h).[@b13-idr-11-125] A retrospective study in a district-level hospital in South Africa reported that the median time delay in administration of antibiotic(s) was 4.2 h.[@b19-idr-11-125] Timing of antibiotic administration at the ED in our study was longer than previously reported at our institution (58--62 min).[@b20-idr-11-125] The explanation is that the definition of "Time Zero" in the previous study was the time severe sepsis or septic shock was diagnosed.

Gram-negative bacteria were obtained predominately in our study, and the antibiotic prescriptions favored monotherapy. The leading organism was *Escherichia coli*, which was similar to previous reports from our hospital.[@b20-idr-11-125],[@b21-idr-11-125] However, in resource-limited settings, the expert consensus recommendation[@b22-idr-11-125] and the latest SSC[@b23-idr-11-125] suggest that in sepsis a combination of antibiotics should be used, especially in septic shock patients. The results of our study complement this recommendation as nearly 70% of septic shock patients admitted in the MICU had health care-associated infection, and empirical antibiotic monotherapy was associated with 28-day mortality. According to the studies of Kumar et al,[@b24-idr-11-125],[@b25-idr-11-125] combination antibiotic therapy improved the mortality in septic shock patients. A previous study in Thailand reported that combination antibiotic therapy in nosocomial infection reduced the chance of inappropriate antibiotics.[@b26-idr-11-125] However, our results did not show a significant benefit of the appropriateness of antibiotics in mortality outcome ([Table 4](#t4-idr-11-125){ref-type="table"}).

In addition to the time interval of antibiotic administration, the time interval of lactate measurement is also a predictor of mortality. The lactate level encourages physicians to recognize sepsis early and initiate prompt intervention. The SSC recommends that the physician order a lactate level measurement as the initial laboratory investigation. However, the compliance in this regard was poor. According to the IMPreSS study,[@b11-idr-11-125] compliance in the measurement of lactate in Asia was only 48.3%, while the compliance in our study was even lower at 40%. Moreover, in a Thai shock survey of 2013,[@b27-idr-11-125] 533 physicians stated that lactate measurement was done in only 16% of cases.

An impeding factor of the appropriate timing of antibiotic administration and lactate measurement is believed to involve the complex illness of the patient which contributes to the difficulty of identifying a patient with sepsis. A low patient-to-nurse ratio and a lack of awareness of the clinicians to recognize sepsis are also the postulated factors.

Overall, the in-hospital mortality rate of septic shock patients was 49.3%, which was similar to the result from a previous study.[@b12-idr-11-125] Surprisingly, in our multivariate analysis, time from the diagnosis of sepsis to antibiotic administration was not associated with 28-day mortality. However, the results confirmed outcomes of a recent meta-analysis of 11 studies that showed no mortality benefit of antibiotic administration within 3 h of the ED triage or within 1 h from septic shock recognition.[@b28-idr-11-125]

We also found that hospital admission of septic shock patients on the weekends was related to mortality. Few studies revealed the same results.[@b29-idr-11-125],[@b30-idr-11-125] The possible explanation of the "weekend effect" may be the limited resources, including physicians and nursing staff personnel, and higher rates of nonadherence to the protocols during the weekend.

Our study has some limitations. The study is retrospective in nature and was conducted at a single center. In addition, the protocol and infrastructure were not similar to other institutes, thereby making comparison difficult. Since this study is retrospective in nature, some incomplete patient data were excluded, which led to bias and the incapability to establish direct cause and effect. We reviewed data from charts and electronic medical records. Therefore, the diagnosis of sepsis and the exact time of "Time Zero" in some patients were missed. Due to our sample size limitation, this study could not clearly determine the effects on the 28-day mortality rate in terms of the antibiotic administration and lactate measurement time intervals.

Conclusion
==========

In conclusion, septic shock patients from the ED who were admitted to the MICU had a shorter duration of sepsis to antibiotic administration time and received more appropriate antibiotics than those from the hospital wards. The combination of antibiotic therapy and hospital admission on a weekend were associated with mortality outcome. These findings suggest that systemic intervention needs to be considered to improve the quality of care, especially in hospital wards. Future qualitative studies should be done to examine and explain the causes of delayed antibiotic administration at each stage, lactate measurement timing, and also the "weekend effect". There are relatively few published studies concerning the specific effects of weekend admission in sepsis and septic shock.
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![Flowchart of recruitment process.\
**Abbreviation:** MICU, medical intensive care unit.](idr-11-125Fig1){#f1-idr-11-125}

![Intervals for stages in the process of antibiotic administration and lactate measurement by sources of MICU admission.\
**Abbreviations:** ED, emergency department; MICU, medical intensive care unit.](idr-11-125Fig2){#f2-idr-11-125}

###### 

Characteristics of the patients

  Characteristics                               All patients (N=150)   Admission source   *P*-value          
  --------------------------------------------- ---------------------- ------------------ ------------------ --------
  Percentage of patients                        100                    41.3               58.7               --
  Age at admission (years), median (IQR)        64 (52--79)            65 (60--81)        61 (48--77)        0.27
  Male                                          86 (57.3)              37 (59.7)          49 (55.7)          0.63
  Time at admission                                                                                          
   Night time                                   45 (30)                22 (35.5)          23 (26.1)          0.21
   Weekend                                      46 (30.7)              21 (33.9)          25 (28.4)          0.47
  Comorbidities                                                                                              
   Malignancy                                   53 (35.3)              11 (17.7)          42 (47.7)          \<0.01
   Solid                                        20 (13.3)              8 (12.9)           12 (13.6)          0.03
   Hematologic                                  33 (22.0)              3 (4.8)            30 (34.1)          \<0.01
   Heart disease                                35 (23.3)              19 (30.6)          16 (18.2)          0.08
   HTN                                          34 (22.7)              21 (33.9)          13 (14.8)          \<0.01
   DM                                           31 (20.7)              18 (29)            13 (14.8)          0.03
   CKD                                          22 (14.7)              13 (20.9)          9 (10.2)           0.07
   Chronic lung disease                         20 (13.3)              13 (20.9)          7 (7.9)            0.02
   Chronic liver disease                        13 (8.7)               3 (4.8)            10 (11.4)          0.16
   Others                                       36 (24)                17 (27.4)          19 (21.6)          0.41
  Health care-associated infection              103 (68.7)             32 (51.6)          71 (80.7)          \<0.01
  Source of infection                                                                                        
   Pneumonia                                    59 (39.3)              28 (45.2)          31 (35.2)          0.22
   Intra-abdominal infection                    31 (20.7)              13 (20.9)          18 (20.4)          0.94
   UTI                                          19 (12.7)              11 (17.7)          8 (9.1)            0.12
   Skin and soft tissue                         11 (7.3)               2 (3.2)            9 (10.2)           0.10
   Catheter-related infection                   3 (2)                  1 (1.6)            2 (2.3)            0.78
   IE                                           2 (1.3)                1 (1.6)            1 (1.1)            0.80
   CNS infection                                1 (0.7)                0 (0)              1 (1.1)            0.49
   Others                                       2 (1.3)                0 (0)              2 (2.3)            0.23
   Unknown                                      22 (14.7)              7 (11.3)           15 (17.0)          0.33
  Lactate measurement at time zero              60 (40)                27 (43.5)          33 (37.5)          0.45
  Lactate level (mmol/L), median (IQR)          3.3 (1.6--6.6)         3.4 (1.2--6.6)     3.3 (1.9--6.7)     0.49
  SOFA score, median (IQR)                      8 (6--10)              8 (6--10)          8 (6--10)          0.20
  Outcomes                                                                                                   
   ED LOS (h)                                   --                     5 (3--6)           --                 --
   MICU LOS (days), median (IQR)                4 (1--7)               2 (1--7)           5 (2--7)           0.01
   Ward LOS after events (days), median (IQR)   8 (1--23) (N=110)      5 (3--12) (N=31)   8 (1--30) (N=79)   0.07
   28-day mortality                             64 (42.7)              22 (35.5)          42 (47.7)          0.13
   In-hospital death                            74 (49.3)              26 (41.9)          48 (54.5)          0.13

**Note:** Data are presented as n (%) unless otherwise indicated.

**Abbreviations:** ED, emergency department; IQR, interquartile range; HTN, hypertension; DM, diabetes mellitus; CKD, chronic kidney disease; UTI, urinary tract infection; IE, infective endocarditis; CNS, central nervous system; SOFA, sequential organ failure assessment; LOS, length of stay; h, hour; MICU, medical intensive care unit.

###### 

Microbiological results in our septic shock patients

  Culture data                                                                   Number (%) of patients or organisms
  ------------------------------------------------------------------------------ -------------------------------------
  Total number of patients                                                       150
   With negative culture results                                                 65 (43)
   With positive culture results                                                 85 (57)
  Sample type of positive culture results (n=85 patients)                        
   Blood                                                                         40 (48)
   Sputum                                                                        32 (38)
   Urine                                                                         19 (23)
   Wound                                                                         5 (6)
   Body fluid                                                                    3 (4)
  Total number of organisms isolated[a](#tfn3-idr-11-125){ref-type="table-fn"}   104
  Gram-positive organisms                                                        23 (22)
   MSSA                                                                          10 (10)
   *Enterococcus faecalis*                                                       7 (6)
   *Streptococcus pneumoniae*                                                    3 (3)
   MRSA                                                                          3 (3)
  Gram-negative organisms                                                        78 (75)
   *Escherichia coli*                                                            29 (28)
   *Klebsiella pneumoniae*                                                       19 (18)
   *Pseudomonas aeruginosa*                                                      13 (12)
   *Acinetobacter baumannii*                                                     12 (11)
   *Proteus mirabilis*                                                           2 (2)
   Others                                                                        3 (3)
  Fungus                                                                         3 (3)

**Note:**

Percentages of organisms were calculated using the total number of organisms isolated as the dominator.

**Abbreviations:** MSSA, methicillin-sensitive *Staphylococcus aureus*; MRSA, methicillin-resistant *Staphylococcus aureus*.

###### 

Initial empiric antibiotic use

  Variable                                         Number (%) of patients or antibiotics
  ------------------------------------------------ ---------------------------------------
  Number of initial antibiotics (N=150 patients)   
   1                                               92 (61.3)
   2                                               52 (34.7)
   3                                               6 (4)
  Initial drug, by class (N=213 antibiotics)       
   Aminoglycosides                                 1 (0.5)
   Carbapenems                                     90 (42.3)
   Cephalosporins                                  42 (19.7)
   Clindamycin                                     3 (1.4)
   Penicillins                                     3 (1.4)
   Piperacillin--tazobactam                        15 (7.0)
   Fluoroquinolones                                12 (5.6)
   Metronidazole                                   7 (3.3)
   Vancomycin                                      17 (7.9)
   Colistin                                        18 (8.4)
   Others                                          5 (2.3)

###### 

Results of the multivariate analysis of parameters and 28-day mortality.

  Variables               Variables               Reference               Adjusted OR   95% CI       *P*-value
  ----------------------- ----------------------- ----------------------- ------------- ------------ -----------
  Number of antibiotics   ≤1 (50th percentile)    \>1 (50th percentile)   19.3          2.4--153.2   \<0.01
  SOFA score              \>8 (50th percentile)   ≤8 (50th percentile)    13.2          2.1--83.8    \<0.01
  Admission on weekend    Yes                     No                      24.4          2.9--199.8   \<0.01

**Notes:** Only significant variables are shown (N59). The risk factors and confounders considered were age (years), lactate level (mmol/L), time zero to antibiotic administration (h), time zero to lactate measurement (h), health care-associated infection, and appropriateness of antibiotic.

**Abbreviations:** OR, odds ratio; CI, confidence interval; SOFA, sequential organ failure assessment.
